Immunization, Hib3 in Europe & Central Asia
Europe & Central Asia: Immunization, Hib3 was 93.2% in 2024. ▲ Rising
Immunization, Hib3 in Europe & Central Asia, 1992–2024
Source: WHO and UNICEF (http://www.who.int/immunization/monitoring_surveillance/en/). Measured in % of children ages 12-23 months.
Analysis
In 2024, immunization, hib3 in Europe & Central Asia stood at 93.2%.
That represents a change of down 0.4% on the previous year and up 23.5% over ten years.
Over the whole period, immunization, hib3 in Europe & Central Asia peaked at 93.6% in 2023 and was at its lowest, 7.1%, in 1992.
Europe & Central Asia ranks 5th of 43 groups on this measure, in the top 10%.
The long-run direction has been consistently rising across the 33 years of available data.
Immunization, Hib3 in Europe & Central Asia, year by year
| Year | % of children ages 12-23 months | Change |
|---|---|---|
| 1992 | 7.1% | — |
| 1993 | 14.0% | +98.9% |
| 1994 | 14.7% | +4.7% |
| 1995 | 15.3% | +3.9% |
| 1996 | 16.3% | +7.1% |
| 1997 | 19.0% | +16.3% |
| 1998 | 30.2% | +59.1% |
| 1999 | 33.7% | +11.3% |
| 2000 | 37.6% | +11.9% |
| 2001 | 39.2% | +4.1% |
| 2002 | 41.6% | +6.2% |
| 2003 | 42.1% | +1.0% |
| 2004 | 43.0% | +2.3% |
| 2005 | 43.7% | +1.6% |
| 2006 | 45.3% | +3.6% |
| 2007 | 58.4% | +28.9% |
| 2008 | 64.7% | +10.8% |
| 2009 | 71.9% | +11.2% |
| 2010 | 74.0% | +2.9% |
| 2011 | 76.2% | +3.0% |
| 2012 | 79.6% | +4.5% |
| 2013 | 78.2% | -1.8% |
| 2014 | 75.4% | -3.5% |
| 2015 | 75.8% | +0.5% |
| 2016 | 75.6% | -0.2% |
| 2017 | 75.5% | -0.2% |
| 2018 | 77.8% | +3.1% |
| 2019 | 79.7% | +2.4% |
| 2020 | 79.5% | -0.2% |
| 2021 | 80.2% | +0.9% |
| 2022 | 92.5% | +15.3% |
| 2023 | 93.6% | +1.1% |
| 2024 | 93.2% | -0.4% |
Biggest year-on-year movements
Years where Immunization, Hib3 in Europe & Central Asia changed far more than this series normally does. A large move can be a real event or a change in how the figure was measured — the source note below says who published it.
| Year | Change | From | To |
|---|---|---|---|
| 1993 | +98.9% | 7.1% | 14.0% |
| 1998 | +59.1% | 19.0% | 30.2% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 1990s | 18.8% | 7.1% | 33.7% | 8 |
| 2000s | 48.7% | 37.6% | 71.9% | 10 |
| 2010s | 76.8% | 74.0% | 79.7% | 10 |
| 2020s | 87.8% | 79.5% | 93.6% | 5 |
More health data for Europe & Central Asia
- Population ages 40-44, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 45-49, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 15-64, male, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 45-49, female, annual growth rate 0.9265 % change on previous year (2025)
- Population ages 40-44, male, per capita 0.0351 units per person (2025)
- Population ages 40-44, male, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 05-09, male, annual growth rate -1.6 % change on previous year (2025)
- Population ages 40-44, male, annual growth rate 0.3995 % change on previous year (2025)
- Population ages 40-44, female, per capita 0.0352 units per person (2025)
- Population ages 35-39, female, per capita 0.0355 units per person (2025)
Frequently asked questions
- What is immunization, hib3 in Europe & Central Asia?
- Immunization, hib3 in Europe & Central Asia was 93.2% in 2024, according to WHO and UNICEF (http://www.who.int/immunization/monitoring_surveillance/en/).
- What is the highest immunization, hib3 recorded in Europe & Central Asia?
- The highest recorded value was 93.6% in 2023.
- What is the lowest immunization, hib3 recorded in Europe & Central Asia?
- The lowest recorded value was 7.1% in 1992.
- How does Europe & Central Asia rank for immunization, hib3?
- Europe & Central Asia ranks 5th out of 43 groups with data for 2024.
- Is immunization, hib3 rising or falling in Europe & Central Asia?
- Over the last ten years it is up 23.5%. The long-run trend across the full record is rising.
- Where does this Europe & Central Asia data come from?
- The figures come from WHO and UNICEF (http://www.who.int/immunization/monitoring_surveillance/en/), published as part of Immunization, Hib3 (% of children ages 12-23 months). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 33 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
Child immunization, Hib3, measures the percentage of children ages 12-23 months who received Hib3 vaccinations before 12 months or at any time before the survey. A child is considered adequately immunized against Hib3 after receiving three doses of Haemophilus influenzae type b vaccine.